以色列国防军对创伤儿科患者使用冻干血浆进行复苏的经验
该研究基于以色列国防军创伤登记处,纳入2013年4月至2018年6月由高级生命支持人员在伤点使用冻干血浆(FDP)复苏的18岁以下创伤患儿。共679名儿童接受治疗,其中33名(5%)在伤点接受了FDP;80%为穿透伤,多数接受1单位血浆,54%同时使用氨甲环酸,48%输注晶体液,33%接受了额外救命干预。作者结论认为,儿科理想复苏液体尚未确定,但采用与成人相似的策略似乎合理;在以色列国防军医疗队中,创伤失血性休克的首选复苏液体是伤点输注的冻干血浆,本研究证明院前对受伤儿童使用FDP是可行的。
要点
- 在以色列国防军创伤登记处中,679名接受治疗的儿童里有33名(5%)在伤点接受了FDP。
- 接受FDP的患儿中80%为穿透伤,多数接受1单位血浆。
- 54%的患儿同时接受了氨甲环酸(TXA)治疗,48%输注了晶体液。
- 33%的患儿还接受了额外的救命干预。
- 作者认为,在以色列国防军医疗队中,创伤失血性休克的首选复苏液体是伤点输注的冻干血浆;对儿科患者采用与成人相似的策略似乎合理。
适用人群与场景
- 2013年4月至2018年6月期间,由以色列国防军高级生命支持人员在伤点使用FDP治疗、受伤时年龄小于18岁的创伤患者。
处置流程与药物剂量
- 在以色列国防军医疗队中,创伤失血性休克的首选复苏液体是伤点输注的冻干血浆。
- 接受FDP的患儿中多数接受1单位血浆;54%同时接受氨甲环酸(TXA)治疗,48%输注晶体液。
研究设计与关键结果
- 研究类型为回顾性描述性研究,证据等级为level IV。
- 共679名儿童接受以色列国防军医疗人员治疗,其中33名(5%)在以色列国防军创伤登记处被识别为在伤点接受了FDP。
- 接受FDP的患儿中80%为穿透伤,多数接受1单位血浆,54%同时接受TXA治疗,48%输注晶体液,33%接受了额外救命干预。
证据类型、等级与局限
- 证据类型:回顾性描述性研究,证据等级level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,儿科理想复苏液体尚未确定,但采用与成人相似的策略似乎合理。
- 在以色列国防军医疗队中,创伤失血性休克的首选复苏液体是伤点输注的冻干血浆;本研究证明院前对受伤儿童使用FDP是可行的,并进一步支持对儿科创伤患者使用FDP的信心。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: With the growing recognition of the disadvantages of crystalloid- and colloid-based resuscitation and the advantages of using blood products as the preferred resuscitation fluid, the Israel Defense Forces Medical Corps (IDF-MC) adopted plasma as the primary volume resuscitation regimen in 2013. While data are accumulating for prehospital plasma transfusion, little to no data exist regarding using plasma as a prehospital resuscitation fluid for traumatized pediatric patients.
METHODS: All patients treated by the IDF-MC personnel are recorded in the IDF Trauma Registry, a unique prehospital trauma registry. All patients treated by the IDF advanced life support providers with FDP at the point of injury between April 2013 and June 2018 who were younger than 18 years at the time of injury were included.
RESULTS: Six hundred seventy-nine children were treated by IDF medical providers, of whom 33 (5%) were identified in the IDF Trauma Registry as having received FDP at the point of injury. Most patients (80%) were treated for penetrating injuries. Most patients received one plasma unit. Fifty-four percent of the patients were also treated by Tranexamic Acid (TXA) and 48% were transfused with crystalloids. In 33% of patients, additional life-saving interventions were performed.
CONCLUSION: While the ideal resuscitation fluid for the pediatric population remains to be determined, it seems reasonable to pursue a similar approach to that of applied that for adults. In the IDF-MC, the resuscitation fluid of choice for trauma patients in hemorrhagic shock is freeze-dried plasma transfused at the point of injury. The current study demonstrates the feasibility of FDP administration in the prehospital scenario for injured children and further supports the growing confidence in the use of FDP for the treatment of pediatric trauma patients.
LEVEL OF EVIDENCE: Retrospective descriptive study, level IV.
参考来源
- Nadler R, Mozer-Glassberg Y, Gaines B, et al. The Israel Defense Forces experience with freeze-dried plasma for the resuscitation of traumatized pediatric patients. J Trauma Acute Care Surg. 2019. PMID: 31425470. doi:10.1097/TA.0000000000002477
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。